2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Primary Myelofibrosis
41
Myeloproliferative Disorders
30
Polycythemia Vera
28
Leukemia, Myeloid, Acute
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Leukemia
17
Myelodysplastic Syndromes
15
Thrombocythemia, Essential
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10
Neoplasms
9
Multiple Myeloma
9
Graft vs Host Disease
9
Breast Neoplasms
9
Pancreatic Neoplasms
8
Leukemia, Myelomonocytic, Chronic
8
Recurrence
7
Myelodysplastic-Myeloproliferative Diseases
7
Lymphoma, Non-Hodgkin
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Hematologic Neoplasms
6
Prostatic Neoplasms
5
Lymphoma, T-Cell
5
Lymphoma
5
Leukemia, Myeloid, Chronic-Phase
5
Hodgkin Disease
5
Hematologic Diseases
5
Colorectal Neoplasms
5
Thrombocytosis
4
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
4
Carcinoma, Non-Small-Cell Lung
4
Interventions
Tamoxifen
25
Radiotherapy
15
Chemotherapy, Adjuvant
11
Anastrozole
11
Specimen Handling
10
Neoadjuvant Therapy
8
Letrozole
8
Biopsy
7
Radiation
6
Mastectomy, Segmental
6
Magnetic Resonance Spectroscopy
6
Immunohistochemistry
5
Gene Expression Profiling
5
exemestane
4
Surgical Procedures, Operative
4
Sentinel Lymph Node Biopsy
4
Radiotherapy, Intensity-Modulated
4
Radiotherapy, Conformal
4
Psychiatric Rehabilitation
4
Mass Spectrometry
4
Early Intervention, Educational
4
Counseling
4
afimoxifene
3
Trastuzumab
3
Surveys and Questionnaires
3
Reverse Transcriptase Polymerase Chain Reaction
3
Radiation Dose Hypofractionation
3
Methods
3
Mastectomy
3
High-Energy Shock Waves
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Intraductal, Noninfiltrating
×
ruxolitinib
×
Clear all
NCT02928978
2026-04-13
TBCRC042
Baylor Breast Care Center
Phase 2
Completed
84 enrolled